What the Lawsuits Allege
The litigation involves Medtronic MiniMed 600-series insulin pumps, specifically the 630G and 670G models, which people with diabetes use to automatically deliver insulin. At issue is a small plastic retainer ring that locks the insulin cartridge into place. Plaintiffs allege the ring could crack, break, or go missing, letting the cartridge shift out of alignment so the pump delivered too much or too little insulin.
Either error can be dangerous. Too much insulin can cause severe hypoglycemia leading to seizures or loss of consciousness, while too little can cause hyperglycemia and diabetic ketoacidosis. Plaintiffs allege Medtronic knew about the design problem well before the recall and failed to adequately warn patients and doctors. Medtronic disputes the claims.
The Class I Recall
Medtronic notified customers about the broken or missing retainer ring in late 2019, and in February 2020 the FDA designated the action a Class I recall, its most serious category, affecting roughly 322,000 devices in the United States. The remedy was a replacement pump with an updated, more durable retainer ring at no charge. The FDA later issued a warning letter criticizing aspects of how Medtronic handled the defect, and additional safety actions addressed battery-related issues on the 600 and 700 series.
A recall and free replacement address the device itself, but they do not compensate someone who was already harmed by a dosing error. That is the gap the injury lawsuits aim to fill.
Where the Cases Stand
Unlike many device cases, the MiniMed injury claims have not been gathered into a federal MDL. The most advanced cases are in California state court, where a group of bellwether cases survived Medtronic attempts to dismiss them, including on a federal-preemption theory, and survived an appeal by Medtronic in 2025, clearing the way toward trial. A separate securities case brought by investors, which is distinct from the injury claims, was dismissed and is on appeal.
No global settlement has been reached as of this update. Eligibility generally centers on having used a recalled MiniMed 630G or 670G pump and suffered an injury from an insulin dosing error, and deadlines vary by state, so anyone affected should seek an individual assessment promptly.
How to Get Legal Help
If you or a family member fits the description here, a consultation with a lawyer who handles this specific litigation is the reliable next step. Deadlines vary and can be unforgiving, most of these firms offer a free review, and these cases are typically taken on contingency, so you pay nothing unless they recover for you.
To follow filings, trial outcomes, and any settlement news, bookmark this page and subscribe to LawsuitWatch alerts.
Free Legal Evaluation
Do You Qualify to File a Claim?
Our network of verified plaintiff attorneys offers free, no-obligation case evaluations. Contingency fee representation means you pay nothing unless you win.
MiniMed Lawsuit: The Medtronic Insulin Pump Cases: Frequently Asked Questions
Answers to the most common questions about this case and your legal options.
What is the MiniMed lawsuit about?
Medtronic MiniMed 600-series insulin pumps, the 630G and 670G, whose plastic retainer ring could crack, break, or go missing, letting the cartridge misalign so the pump delivered too much or too little insulin. Plaintiffs allege Medtronic knew and failed to warn; Medtronic disputes this.
What injuries are alleged?
Severe hypoglycemia, which can cause seizures or loss of consciousness, from too much insulin, and hyperglycemia and diabetic ketoacidosis from too little. The dosing errors are the core of the injury claims.
Was there a recall?
Yes. The FDA designated it a Class I recall, its most serious, in February 2020, affecting roughly 322,000 U.S. devices, with a free replacement pump featuring an updated retainer ring. The FDA later criticized aspects of Medtronic handling.
Is there a MiniMed MDL?
No federal MDL. The most advanced injury cases are in California state court, where bellwether cases survived Medtronic dismissal efforts and a 2025 appeal and are heading toward trial. A separate investor securities case is distinct and was dismissed.
Who may qualify?
Generally someone who used a recalled MiniMed 630G or 670G pump and suffered an injury from an insulin dosing error. A recall replacement does not compensate prior harm, and deadlines vary by state, so a prompt individual assessment matters.